DONEGAL MUTUAL INSURANCE CO purchased $293K of DGICA

DONEGAL MUTUAL INSURANCE CO purchased 17,000 shares of DONEGAL GROUP INC (DGICA) at an average of $17.24 ($17.15–$17.33, $0.29M total) across 2 trades over 2026-05-26 to 2026-05-27.

Original reporting
SEC EDGAR · DONEGAL MUTUAL INSURANCE CO
Published May 28, 2026, 4:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 6, 2026, 8:40 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$DGICA
Neutral
medium confidence
Mentioned
$DGICA
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$DGICANeutralLow
01

Why it matters

This provides a new, dated record of an open-market purchase by a significant shareholder, which may slightly influence sentiment but does not include any new company performance, guidance, or strategic event.

02

Market read

Traders may monitor DGICA for additional insider activity, but the disclosure alone is unlikely to drive a sustained repricing without accompanying fundamentals.

03

What to watch

The filing does not state intent, timing constraints, or whether the buyer has other concurrent transactions; traders should wait for follow-on Form 4s or company fundamentals.

Relevance 5/10Novelty 4/10Timing: SEC Form 4 filed 2026-05-28, covering purchases on 2026-05-26 to 2026-05-27.

Background

The article is an SEC Form 4 insider transaction disclosure for Donegal Group Inc (DGICA), reported by Donegal Mutual Insurance Co as a 10% owner.

Company-level read

Ticker impact

$DGICANeutralMedium confidence
Context

Donegal Mutual Insurance Co, a 10% owner, bought 17,000 DGICA shares in open-market trades at about $17.15 to $17.33 per share.

Expected impact

Near-term impact is likely limited; any effect would be sentiment-driven and should fade unless followed by additional disclosures or company-specific news.

Evidence & confidence

Form 4 insider purchases are new information, but the transaction is small relative to typical market-moving thresholds and provides no guidance, deal, or operational change.

Market effects

Minimal, as this is a single-company insider transaction with no sector-wide regulatory or operational change.

None indicated; the filing is company-specific.

None indicated; no cross-border deal, macro shock, or global supply-chain event is mentioned.

Counterpoint

A 10% owner open-market buy can be routine liquidity management or diversification rather than a strong bullish signal, especially without a 10b5-1 plan.

Key entities

  • Donegal Group Inc

    Subject of the Form 4 insider transaction disclosure (DGICA).

  • Donegal Mutual Insurance Co

    Reporter of the open-market purchase of DGICA shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$DGICAMed

Donegal Group Inc (DGICA) Q3 2026 Earnings Call Highlights: Ninth Straight Profitable

Donegal Group (DGICA) reported Q3 2026 earnings, highlighting a 9th straight profitable quarter. CEO Kevin Burke discussed cloud migration timelines and AI integration. Commercial lines saw a 3.2% rise in core loss ratio due to workers' comp and liability losses. Personal lines improved with a 5.4% decline in net premiums written and a 146% increase in new business. Weather-related losses were $19.1M, and investment income rose 5% to $14.7M.

$DGICAMed

Donegal Group Q3 2026 slides: profitability holds amid soft market

Donegal Group Inc. (DGICA) reported Q3 2026 earnings with adjusted EPS of $0.50, beating estimates, but revenue of $209.7M missed forecasts. Underwriting profitability persisted with a combined ratio of 96.5%, though premiums declined. The stock rose 2.07% premarket. Management highlighted strategic initiatives and conservative investment strategies amid soft market conditions.

$DGICAMed

Donegal Group Inc. Announces Third Quarter and First Nine Months of 2026 Results

DONEGAL GROUP INC (DGICA) filed an SEC Form 8-K — Results of Operations and Financial Condition. EXHIBIT 99.1 Donegal Group Inc. Announces Third Quarter and First Nine Months of 2026 Results MARIETTA, Pa., Oct. 29, 2026 (GLOBE NEWSWIRE) -- Donegal Group Inc. (NASDAQ: DGICA) and (NASDAQ: DGICB) today reported its financial results for the third quarter and first nine months o